Exposed Identity: Microplastics Under The Raman Microscope

The issue of microplastic pollution is raising serious concern among scientists and the society at large 1,2. Microplastics, tiny plastic fragments ranging from 1 micron…
Read more
The issue of microplastic pollution is raising serious concern among scientists and the society at large 1,2. Microplastics, tiny plastic fragments ranging from 1 micron…
Read more
Global sustainability challenges – chronic hunger, loss of species habitat, water shortage, and the continuing rise of greenhouse gas emissions from human activities – are…
Read more
Inflammatory diseases of the gut are on the rise. In North America and Europe, more than 0.3% of the population suffers from inflammatory bowel diseases…
Read more
Every day, millions of people enjoy the pleasure and benefits of personal care products (PCPs). From hair colors to lipsticks, body lotions to cosmetics, fragrances…
Read more
Some pathogens give our immune system quite a hard time, such as pathogens like Influenza, where each season evolves new flu variants that reinfect, even…
Read more
The eye is one of the most important and complex organs in our body. A variety of causes, including injuries or diseases such as diabetes,…
Read more
Many modern products that are sold require highly specialized separation techniques for their purification and preparation. Some of the separations that have become more common…
Read more
The paleoecological study of several wetland areas in the Sierra Nevada mountains of Spain led by researchers from the Department of Stratigraphy and Paleontology at…
Read more
By 2050, 20% of the world’s population will be 60 years old or more. Under this scenario, diseases related to aging will represent an overwhelming…
Read more
Soil sustains life by the virtue of the nutrients and moisture it holds. Predicting the dynamics of soil moisture is of great importance for agricultural…
Read more
Immunotherapy with checkpoint blockade has revolutionized cancer treatment in the last decade. With the initial FDA approval of CTLA-4 blockade with ipilimumab in 2011 followed…
Read more